The Healthcare AI Operating Model in 2026

Table of Contents

1. Why Healthcare Needs a Deliberate AI Operating Model
2. The Current State of Healthcare AI Adoption
3. Core Components of a Healthcare AI Operating Model
4. Governance and Regulatory Readiness
5. Build vs. Buy: The Strategic Framework
6. Vendor Selection and Integration
7. The AI Maturity Curve in Healthcare
8. From Pilot to Portfolio-Wide Deployment
9. Common Pitfalls and How to Avoid Them
10. Next Steps: Building Your Operating Model

---

Why Healthcare Needs a Deliberate AI Operating Model

Healthcare organisations in 2026 are no longer asking whether to invest in AI. They’re asking how to do it without breaking compliance, burning money on failed pilots, or creating fragmented systems that clinicians won’t use.

The problem is clear: healthcare AI adoption has accelerated dramatically, but most health systems lack a coherent operating model to govern it. According to research from healthcare IT news on AI opportunities and challenges in 2026, the gap between AI ambition and execution remains significant. Health systems are deploying point solutions—diagnostic tools, administrative automation, scheduling optimisers—without connecting them to a unified strategy, data architecture, or governance framework.

This leads to predictable outcomes: siloed implementations, duplicate vendor relationships, poor data quality, clinician resistance, and audit risk.

A deliberate AI operating model solves this. It defines how your organisation will:

• Identify, evaluate, and prioritise AI opportunities across clinical and operational domains
• Govern AI decisions with clinician input, compliance oversight, and evidence standards
• Build versus buy technology, with clear criteria for each path
• Select and integrate vendors without fragmenting your data or architecture
• Measure outcomes in clinical, operational, and financial terms
• Scale pilots into sustainable, organisation-wide deployments
• Maintain regulatory readiness as you grow your AI footprint

Healthcare organisations that build this model in 2026 will have a significant advantage over those that continue ad-hoc adoption. They’ll ship faster, spend less, retain clinician trust, and pass audits without panic.

---

The Current State of Healthcare AI Adoption

Healthcare AI in 2026 is no longer experimental. It’s operational, but chaotic.

Deloitte’s analysis of agentic AI in healthcare shows that health systems are increasingly deploying autonomous agents to handle workflow tasks—clinical documentation, prior authorisation, discharge scheduling, supply chain optimisation. These agents are delivering measurable ROI: 20–40% reduction in administrative time, faster patient throughput, fewer clinician interruptions.

But adoption is fragmented. A typical mid-sized health system in 2026 might have:

• Three to five diagnostic AI tools (radiology, pathology, ophthalmology) from different vendors
• One or two administrative automation platforms (scheduling, billing)
• Ad-hoc chatbots and documentation assistants deployed by individual departments
• Spreadsheet-driven workflows that haven’t been touched by AI
• No unified data lake or AI platform; each tool has its own data pipeline
• Compliance and governance handled case-by-case, not systematically

This fragmentation creates real costs:

Technical debt: Each vendor integration requires custom ETL, API wrappers, and manual data mapping. When vendors change pricing or deprecate APIs, you’re stuck with expensive re-engineering.

Clinician friction: Staff trained on one tool’s interface encounter a different UX in another. Documentation flows are inconsistent. Trust erodes when outcomes vary unexpectedly.

Data quality issues: Without a unified data governance framework, AI models train on inconsistent, poorly-validated data. Accuracy suffers. Audit trails break.

Compliance risk: Vendor contracts vary on data residency, model transparency, and liability. You can’t answer auditors’ questions about which AI systems touch sensitive data or how models are validated.

Wasted spend: You’re paying for overlapping capabilities, redundant infrastructure, and failed pilots that nobody learned from.

McKinsey’s healthcare insights collection reinforces this picture: health systems are investing heavily in AI but struggling to measure ROI and scale beyond proof-of-concept.

The solution isn’t to slow down adoption. It’s to build an operating model that channels AI investment strategically, governs it transparently, and scales it sustainably.

---

Core Components of a Healthcare AI Operating Model

A healthcare AI operating model sits at the intersection of strategy, technology, governance, and culture. It has six core components:

1. AI Strategy and Prioritisation

Your AI strategy should answer: Which AI investments will move the needle on your organisation’s top three to five strategic priorities?

For most health systems, those priorities are:

• Clinical quality and safety: Reducing adverse events, improving diagnostic accuracy, shortening time-to-treatment
• Operational efficiency: Reducing administrative overhead, improving throughput, optimising resource allocation
• Financial performance: Improving revenue cycle, reducing denials, lowering supply chain costs
• Clinician and staff experience: Reducing documentation burden, improving scheduling, cutting burnout
• Patient experience: Faster access, better communication, personalised care pathways

Your AI strategy should map specific use cases to each priority, with clear success metrics. A use case like “AI-assisted radiology reporting” maps to clinical quality and clinician experience. “Prior authorisation automation” maps to operational efficiency and financial performance.

The key is to evaluate use cases on three dimensions:

• Impact: Revenue uplift, cost reduction, clinical improvement, or time saved. Quantify it.
• Feasibility: Data availability, technical complexity, vendor maturity, implementation timeline.
• Risk: Regulatory exposure, clinical validation requirements, change management difficulty, vendor dependency.

Score each use case on these dimensions and build a roadmap. Typically, you’ll prioritise high-impact, low-risk, high-feasibility opportunities first (the “quick wins”), then move into more complex, higher-risk initiatives once you’ve built capability and trust.

2. Data Architecture and Governance

AI is only as good as the data it trains on. Healthcare data is messy: it’s spread across legacy EHRs, billing systems, lab platforms, and departmental databases. It’s inconsistent (same clinical concept recorded differently across systems), incomplete, and heavily regulated.

Your data architecture must:

• Centralise data: Build a unified data lake or warehouse that ingests data from all clinical and operational systems. This is non-negotiable for scaling AI.
• Standardise semantics: Map local data elements to standard vocabularies (SNOMED CT, LOINC, RxNorm). This ensures AI models can generalise across departments and facilities.
• Govern data quality: Define data validation rules, monitor for drift, and flag anomalies. Bad data in = bad AI out.
• Enforce access controls: AI models often need sensitive data (diagnoses, medications, genomics). Your architecture must enforce role-based access, audit logs, and data minimisation principles.
• Enable lineage and auditability: Track where data comes from, how it’s transformed, and where it flows. You’ll need this for regulatory audits.

For most health systems, this means investing in a modern cloud data platform (Snowflake, BigQuery, Redshift) with strong governance tooling. The upfront cost is significant, but it’s the foundation for scaling AI without accumulating technical debt.

3. AI Governance and Oversight

Given the clinical and regulatory stakes, healthcare AI governance can’t be ad-hoc. You need a formal structure:

• AI Governance Committee: Cross-functional group (Chief Medical Officer, Chief Information Officer, Chief Compliance Officer, clinical leads, data scientists) that reviews and approves new AI initiatives. Meets monthly.
• Clinical Validation Framework: Before any AI system touches patient care, it must be validated against a gold standard (human expert consensus, randomised controlled trial, regulatory precedent). Document the validation study and results.
• Explainability and Transparency Standards: For high-stakes decisions (diagnosis, treatment recommendation), the AI system must be able to explain its reasoning. Define which use cases require explainability and which don’t.
• Bias and Fairness Monitoring: Healthcare AI systems can perpetuate or amplify existing inequities. Establish baseline fairness metrics by demographic group and monitor for drift.
• Incident Response and Escalation: Define what constitutes an AI incident (unexpected model behaviour, data breach, clinician safety concern) and who handles it. Have a playbook.

The AMA’s guidance on health systems implementing AI emphasises the importance of clinician engagement in governance. AI systems will only be trusted and used if clinicians have a voice in their design, validation, and deployment.

4. Technology Stack and Integration

Your technology stack should be modular, not monolithic. You’re not choosing a single “AI platform” that does everything. Instead, you’re building a composable stack:

• Data layer: Cloud data warehouse + ETL orchestration (dbt, Airbyte, Informatica)
• AI/ML layer: Model development and training (Python, R, MLflow, Weights & Biases), inference infrastructure (Kubernetes, Ray, Modal)
• Workflow orchestration: Tools to build and deploy AI agents and automations (Temporal, Prefect, custom microservices)
• Integration layer: APIs and webhooks to connect AI systems to clinical workflows and EHR systems
• Monitoring and governance: Model monitoring (Evidently, WhyLabs), data quality (Great Expectations), compliance and audit logging

The stack should be technology-agnostic enough to allow you to swap vendors or build custom solutions without rearchitecting. This is where many health systems get locked into expensive, rigid vendor ecosystems. Avoid it.

5. Change Management and Clinician Adoption

AI only delivers value if clinicians use it. And clinicians will only use it if they trust it, understand it, and see it reduce their workload—not add to it.

Your change management approach should include:

• Workflow redesign: Don’t just bolt AI onto existing workflows. Redesign workflows around what AI can do. If you’re deploying prior authorisation automation, redesign the authorisation process to leverage it.
• Training and support: Clinicians need hands-on training on new AI tools. Provide it. Designate “super-users” in each department who can troubleshoot and advocate for the tool.
• Feedback loops: After deployment, gather feedback from clinicians on what’s working and what’s not. Iterate quickly. Show that you’re listening.
• Transparency on limitations: Be honest about what the AI system can and can’t do. If it’s designed to assist, not replace, say so. If it has accuracy limits, share them.
• Outcome reporting: Share results with clinicians. “This AI tool reduced documentation time by 2 hours per shift” or “This diagnostic assistant improved detection rate by 8%” builds trust and momentum.

6. Vendor and Build Capability

You can’t build everything yourself. You also can’t outsource everything to vendors. You need a balanced approach:

• Core capability: Invest in building core data engineering, AI/ML engineering, and clinical informatics capability in-house. This is your competitive advantage and your insulation against vendor lock-in.
• Vendor partnerships: Use best-of-breed vendors for specific domains (diagnostic AI, scheduling, billing automation) where they have deep expertise and regulatory certification.
• Custom development: Build custom solutions for workflows unique to your organisation or use cases where no vendor solution exists.
• Fractional leadership: If you don’t have a Chief Data Officer, Chief AI Officer, or VP of Engineering, bring in fractional leadership to guide strategy and hiring. PADISO’s CTO advisory services provide this kind of technical leadership for healthcare and biotech organisations.

The balance depends on your organisation’s size, risk tolerance, and strategic priorities. A large integrated health system might invest heavily in in-house capability. A smaller hospital system might rely more on vendors and fractional expertise.

---

Governance and Regulatory Readiness

Healthcare is regulated. FDA, CMS, state health departments, and privacy regulators all have stakes in how you deploy AI. Your operating model must account for this.

FDA and Clinical AI Regulation

The FDA regulates AI/ML-based Software as a Medical Device (SaMD). If your AI system diagnoses, treats, or monitors a disease, the FDA considers it a medical device.

The FDA’s 2023 guidance on AI/ML in medical devices outlines expectations:

• Predetermined Change Control Plans (PCCPs): If your AI model updates automatically (retrains on new data), you must pre-specify how it will change and get FDA approval for the change mechanism, not just the initial model.
• Validation and testing: You must demonstrate that your model works as intended on representative data, including edge cases and demographic subgroups.
• Real-world performance monitoring: After launch, you must monitor model performance in actual clinical use and report degradation or unexpected behaviour.
• Transparency and explainability: For high-risk decisions, you should be able to explain the model’s reasoning.

Not all healthcare AI requires FDA approval. Purely administrative tools (scheduling, billing automation) don’t. But diagnostic, therapeutic, or monitoring tools do. Know the difference.

CMS and Reimbursement

If you’re using AI to support billing or coding, CMS has expectations:

• AI-assisted coding must still be reviewed by a qualified coder. You can’t automate the entire coding process.
• If you’re using AI to predict patient risk or recommend treatment, you must be able to document the clinical rationale, not just the model output.
• Reimbursement claims must be accurate and defensible. If your AI system leads to systematic overbilling, you’re at risk of compliance violations.

Privacy and Data Protection

Healthcare data is protected by HIPAA (in the US), GDPR (in the EU), and equivalent regulations globally. Your AI operating model must respect these:

• Data minimisation: Only use the minimum data necessary for your AI system. If you can build a scheduling AI with anonymised data, don’t use identified patient data.
• Access controls: Enforce role-based access. A radiology AI doesn’t need access to psychiatric records.
• Audit logging: Log who accessed what data, when, and why. You’ll need this for breach investigations and regulatory audits.
• Data residency: Some jurisdictions require healthcare data to stay within their borders. Know your obligations.
• Vendor contracts: Ensure your AI vendors are HIPAA-compliant (or GDPR-compliant, as applicable) and have clear liability and indemnification clauses.

Security and Audit Readiness

As you scale AI, your security posture must keep pace. This includes:

• Model security: Protect your trained models from theft, tampering, or poisoning attacks. Use version control, access restrictions, and encryption.
• Data security: Encrypt data in transit and at rest. Use secure APIs for data access. Monitor for unauthorised access or exfiltration.
• Infrastructure security: Your AI infrastructure (cloud data warehouse, model serving, orchestration) must be hardened. Use VPCs, firewalls, and intrusion detection.
• Compliance frameworks: Many health systems must comply with SOC 2, ISO 27001, or equivalent frameworks. Your AI infrastructure should be designed with these in mind from day one. PADISO’s security audit services help health systems achieve SOC 2 and ISO 27001 readiness, including AI systems and data platforms.

The key is to build compliance into your architecture, not bolt it on afterward. It’s faster, cheaper, and more effective.

---

Build vs. Buy: The Strategic Framework

Every health system faces the same decision repeatedly: should we build this AI capability ourselves, or buy it from a vendor?

There’s no universal answer, but you can use a framework to decide.

Build When:

1. It’s a core competitive differentiator

If the capability directly supports your strategic mission and creates competitive advantage, build it. Example: a health system with a world-class oncology program might build proprietary AI tools for treatment planning and outcome prediction. These tools become a recruiting tool for oncologists and a draw for patients.

2. It requires deep integration with your workflows

Some AI solutions need tight integration with your EHR, billing system, and clinical workflows. If no vendor solution fits your specific workflows, building custom integration is often cheaper and faster than forcing your workflows to fit a vendor’s product.

3. You have the technical talent

Building AI requires data engineers, ML engineers, and clinical informaticists. If you don’t have this talent and can’t hire it, buying is more realistic. But if you do have it (or can hire it), building gives you control and reduces vendor dependency.

4. The use case is unique to your organisation

If you’re solving a problem that’s specific to your health system’s patient population, geography, or clinical model, building is often the only option. Vendors can’t build for every niche.

Buy When:

1. The vendor has FDA approval or clinical validation

If a vendor has already done the hard work of clinical validation and FDA approval, buying saves you months and significant cost. This is especially true for diagnostic tools.

2. The solution is commoditised

Scheduling, billing, basic administrative automation—these are solved problems. Buying from a mature vendor is faster and cheaper than building.

3. You lack internal capability

If you don’t have the talent to build and can’t hire it quickly, buying is the pragmatic choice. You can always build capability later and bring solutions in-house if needed.

4. The vendor has scale and staying power

Vendors with large customer bases can invest in product development, security, and compliance at a scale you can’t match. If the vendor is financially stable and committed to your use case, buying reduces risk.

Hybrid Approach: Build the Connective Tissue

Most health systems should use a hybrid approach:

• Buy best-of-breed solutions for specific domains (diagnostic AI, scheduling, billing automation) from vendors with proven track records.
• Build the connective tissue: data pipelines, integration APIs, workflow orchestration, and governance infrastructure that ties vendor solutions together and connects them to your EHR.
• Build custom solutions for workflows unique to your organisation or use cases where no vendor exists.

This approach gives you the benefits of both: vendor expertise and investment in specific domains, plus control and flexibility in how you integrate and orchestrate them.

---

Vendor Selection and Integration

If you’re buying AI solutions, vendor selection is critical. You’re not just evaluating a product; you’re entering a multi-year partnership that will touch your data, your workflows, and your regulatory posture.

Vendor Evaluation Criteria

1. Clinical Evidence

Ask for published studies demonstrating the vendor’s AI system works as claimed. If it’s a diagnostic tool, ask for validation on your patient population (age, gender, disease prevalence, comorbidities). If the vendor can’t produce evidence, be sceptical.

2. Regulatory Status

If the tool is a medical device, is it FDA-cleared? In which countries? What’s the regulatory pathway going forward? Will the vendor maintain regulatory compliance as the model updates?

3. Data Governance and Privacy

Where does the vendor store your data? Can you keep it on-premises or in your own cloud account? What happens to your data if you stop using the vendor? Can the vendor use your data to train models for other customers? Get these answers in writing.

4. Interoperability and Integration

How does the vendor connect to your EHR, data warehouse, and other systems? Do they have pre-built integrations or will you need custom development? What’s the integration timeline and cost?

5. Explainability and Transparency

Can the vendor explain how the model makes decisions? For high-stakes use cases (diagnosis, treatment recommendation), this is non-negotiable. Some vendors will refuse because their models are proprietary. That’s a red flag.

6. Security and Compliance

Is the vendor SOC 2 certified? ISO 27001 certified? HIPAA-compliant? Do they undergo regular security audits? Ask for audit reports and compliance certifications.

7. Support and SLA

What’s the vendor’s support model? Is there 24/7 clinical support if the system fails? What are the SLAs for uptime and incident response? For mission-critical systems, this matters.

8. Pricing and Lock-in

How is the vendor priced? Per user, per patient, per transaction? Are there volume discounts? What’s the contract term? Exit clauses? Pricing should be transparent and aligned with your usage.

9. Vendor Stability and Roadmap

Is the vendor well-funded? Profitable? Are they pivoting away from healthcare? Do they have a credible roadmap for the next 3–5 years? Vendor failure is a real risk in healthcare AI.

Integration Best Practices

Once you’ve selected a vendor, integration is where many health systems stumble. Here’s how to do it well:

1. Define integration requirements upfront

Before signing the contract, document exactly what data needs to flow where, in what format, at what frequency. Don’t assume the vendor’s default integration will work for you.

2. Use APIs, not file transfers

File-based integration (daily CSV exports) is fragile and doesn’t scale. Use APIs for real-time or near-real-time data flow. If the vendor doesn’t have APIs, that’s a problem.

3. Build an integration layer

Don’t integrate vendor systems directly to your EHR or data warehouse. Build an abstraction layer (API gateway, message broker, data pipeline) that decouples vendor systems from your core infrastructure. This makes it easier to swap vendors later.

4. Test thoroughly

Integration failures often don’t show up until production. Test with realistic data volumes, edge cases, and failure scenarios. Simulate vendor downtime and ensure your systems degrade gracefully.

5. Monitor integration health

Once live, monitor data flow, latency, and error rates. Set up alerts for integration failures. Have a runbook for common issues.

6. Plan for change

Vendors update their APIs and products. Have a process for testing and deploying vendor updates without breaking your workflows.

---

The AI Maturity Curve in Healthcare

Healthcare organisations don’t go from zero to AI-driven overnight. They follow a maturity curve. Understanding where you are on this curve helps you set realistic expectations and plan the next phase.

Stage 1: Ad-Hoc Pilots (Months 0–6)

Characteristics:

• Individual departments or clinicians experimenting with AI tools
• No unified governance or strategy
• Limited data infrastructure; data often siloed in departmental systems
• Success metrics undefined or anecdotal
• No formal change management

Typical initiatives:

• Diagnostic AI trial in radiology or pathology
• Scheduling or administrative automation pilot in a single department
• Chatbot or documentation assistant for clinicians

Outcomes:

• Some quick wins (30–50% time savings in targeted workflows)
• Lots of learning about what works and what doesn’t
• Clinician enthusiasm (or resistance) that informs next steps
• Technical debt from quick integrations and workarounds

Key challenge: Pilots often fail to scale because there’s no underlying data infrastructure or governance model to support them.

Stage 2: Foundational Infrastructure (Months 6–18)

Characteristics:

• Investment in data infrastructure: data warehouse, ETL pipelines, data governance
• Formal AI governance committee established
• Clinical validation framework defined
• Vendor relationships formalised
• Early hiring of data engineers and ML engineers

Typical initiatives:

• Build unified data warehouse ingesting data from EHR, billing, lab systems
• Establish data quality standards and monitoring
• Formalise vendor contracts and integration requirements
• Launch 2–3 strategic AI initiatives with proper governance
• Develop clinician training and change management programs

Outcomes:

• Data quality improves; AI models perform better
• Integration costs drop as reusable pipelines are built
• Governance scales; new AI initiatives move faster
• Clinician adoption improves as workflows are redesigned

Key challenge: Infrastructure investment is expensive and slow to show ROI. Executive patience is required.

Stage 3: Scaled Deployment (Months 18–36)

Characteristics:

• Multiple AI initiatives running in parallel across clinical and operational domains
• Mature data infrastructure supporting real-time and batch analytics
• Governance processes running smoothly; governance committee reviews 5+ initiatives per quarter
• AI team expanded; dedicated roles for data engineering, ML engineering, clinical informatics
• Vendor ecosystem maturing; relationships deepening

Typical initiatives:

• Diagnostic AI deployed across multiple specialties
• Administrative automation across scheduling, billing, supply chain
• Predictive models for patient risk, readmission, length of stay
• Agentic AI for prior authorisation, discharge planning, clinical documentation
• Real-time analytics dashboards for operational decision-making

Outcomes:

• Measurable ROI: 10–20% reduction in administrative costs, 5–15% improvement in clinical outcomes, 20–40% reduction in clinician documentation time
• Clinician adoption high; AI tools are integrated into standard workflows
• Vendor relationships optimised; redundant tools consolidated
• AI literacy improving across organisation

Key challenge: Scaling governance and change management across the organisation. Maintaining data quality and model performance as volume grows.

Stage 4: Organisational AI Capability (Year 3+)

Characteristics:

• AI is embedded in organisational culture and strategy
• Mature, self-sufficient AI team with capability across data engineering, ML engineering, clinical informatics, and product
• Governance is automated where possible; humans focus on high-risk decisions
• Vendor ecosystem is optimised; build vs. buy decisions are strategic, not reactive
• Continuous improvement culture; lessons from pilots are systematised
• AI literacy across organisation; clinicians, executives, and staff understand AI capabilities and limitations

Typical initiatives:

• Autonomous agents handling end-to-end workflows (prior auth, discharge, supply chain)
• Personalised medicine: AI models for treatment selection and outcome prediction
• Predictive maintenance and supply chain optimisation
• Continuous model retraining and performance monitoring
• Proactive regulatory compliance; audit-ready by design

Outcomes:

• Sustained ROI: 15–25% reduction in administrative costs, 10–20% improvement in clinical outcomes, 40–60% reduction in clinician documentation burden
• Competitive differentiation: AI capabilities become a recruiting and retention tool for clinicians and staff
• Vendor independence: ability to swap vendors or build custom solutions without disruption
• Regulatory leadership: recognised as a model for responsible AI deployment

Key challenge: Maintaining momentum and preventing complacency. Staying ahead of regulatory changes and new AI capabilities.

---

From Pilot to Portfolio-Wide Deployment

The graveyard of healthcare AI is full of successful pilots that never scaled. Here’s how to avoid that fate.

The Pilot-to-Scale Playbook

Phase 1: Design the Pilot (Weeks 1–4)

• Define the clinical or operational problem you’re solving. Be specific: “Reduce time radiologists spend on report writing” not “improve radiology efficiency.”
• Identify success metrics. For the radiology example: “Reduce report writing time by 30% while maintaining diagnostic accuracy.”
• Define the pilot scope: Which radiologists? Which exam types? How long will the pilot run? How many cases will you evaluate?
• Identify the vendor or build approach. Run an evaluation process; don’t just pick the first tool you find.
• Secure executive sponsorship and clinical champion. You’ll need both.
• Plan change management: training, feedback loops, communication plan.

Phase 2: Run the Pilot (Weeks 4–12)

• Deploy the AI tool to the pilot group. Start small: 2–3 radiologists, 50–100 cases per week.
• Collect data on time saved, diagnostic accuracy, clinician satisfaction, integration issues.
• Hold weekly feedback sessions with pilot participants. What’s working? What’s not? What would make you use this more?
• Monitor for unintended consequences: Are radiologists over-relying on the tool? Are they missing cases the tool misses? Is there bias in which cases are reviewed?
• Document everything: time logs, accuracy metrics, clinician feedback, integration issues, cost.

Phase 3: Evaluate and Decide (Weeks 12–16)

• Analyse pilot results against success metrics. Did you hit your targets?
• If yes, plan scale-up. If no, diagnose why and decide: iterate the tool, change the workflow, or kill the pilot.
• Present results to governance committee. Get formal approval to scale.
• Identify barriers to scale: training needs, workflow redesign, integration work, cost, vendor readiness.
• Build a scaling roadmap: timeline, resource requirements, success metrics, rollback plan.

Phase 4: Scale (Months 4–12)

• Roll out to the next cohort of users (e.g., all radiologists in your health system). Don’t try to scale to the entire organisation at once.
• Implement standardised training. Use pilot super-users as trainers.
• Monitor closely: performance metrics, clinician adoption, integration health, cost.
• Iterate quickly: if something’s not working, fix it fast. Don’t let problems fester.
• Communicate results regularly: share wins with clinicians and executives. Build momentum.

Phase 5: Sustain and Optimise (Months 12+)

• Transition to steady-state operations. AI tool is now part of standard workflow.
• Establish SLAs and support model. Who handles issues? What’s the response time?
• Monitor model performance continuously. Retrain as needed to maintain accuracy.
• Gather ongoing feedback. Use it to optimise the tool and workflow.
• Plan for the next phase: can you expand to other specialties or use cases?

Common Scaling Mistakes

Mistake 1: Scaling too fast

You had success in a pilot with 2 radiologists and 100 cases per week. Now you want to roll out to 50 radiologists and 5,000 cases per week. This often fails because:

• The tool wasn’t validated on the full diversity of cases, radiologists, and workflows
• Your integration infrastructure can’t handle the volume
• Your change management and training didn’t scale
• Unexpected issues emerge at scale that didn’t show up in the pilot

Rule of thumb: scale in phases. Roll out to 20% of users first. Hit your metrics. Then roll out to the next 30%. Then the rest.

Mistake 2: Ignoring clinician feedback

You had a successful pilot, but only because your pilot participants were enthusiastic early adopters. When you scale to the broader population, you encounter clinicians who are sceptical or resistant.

Don’t ignore them. Understand their concerns. Often, they’re right: the tool doesn’t fit their workflow, or it introduces new problems.

Iterate. Redesign the workflow. Retrain. Get buy-in. Scaling without clinician buy-in is a recipe for failure.

Mistake 3: Not investing in integration and infrastructure

Your pilot ran on a single radiologist’s workstation with manual data handling. Now you need to integrate with your EHR, PACS, and reporting system, handle thousands of cases per day, and ensure 24/7 uptime.

This requires real infrastructure investment: cloud services, API development, monitoring and alerting, disaster recovery.

Budget for it. Don’t cheap out on infrastructure and then wonder why your scaling effort fails.

Mistake 4: Unclear success metrics

Your pilot showed “improved efficiency” but you didn’t measure it rigorously. Now, when you scale, you can’t prove ROI. Executive support wanes. Funding gets cut.

Define success metrics upfront and measure them rigorously. Time saved. Accuracy improved. Cost reduced. Patient outcomes better. Clinician satisfaction higher. Measure all of them.

---

Common Pitfalls and How to Avoid Them

Pitfall 1: Data Quality Disasters

The problem: You build a beautiful data warehouse and train an AI model on it. The model works great in testing. But in production, it fails because the real-world data is different: inconsistent, incomplete, biased.

How to avoid it:

• Invest in data quality upfront. Audit your source systems. Understand data completeness, consistency, and validity before you build AI models.
• Define data quality standards: which fields are required? What’s the acceptable error rate? How will you monitor for drift?
• Use data profiling and validation tools (Great Expectations, Soda, Talend) to monitor data quality continuously.
• When building AI models, use representative training data. If your model will run on data from multiple facilities, train on data from multiple facilities.
• Test models on data they haven’t seen before. Simulate real-world conditions: missing values, outliers, demographic shifts.

Pitfall 2: Vendor Lock-In

The problem: You commit to a vendor’s AI platform. They integrate deeply into your systems. Now you’re dependent on them. They raise prices 50%. You’re stuck.

How to avoid it:

• Build an integration layer between vendor systems and your core infrastructure. Don’t integrate directly to your EHR or data warehouse.
• Insist on data portability. You should be able to export your data and models in standard formats.
• Use open standards and APIs. Avoid proprietary formats that only the vendor can read.
• Maintain in-house capability to build or modify AI systems. Don’t outsource all AI development to vendors.
• Diversify vendors. Don’t bet your entire AI strategy on one vendor.
• PADISO’s platform development services help health systems build vendor-agnostic data and AI infrastructure that’s portable and defensible.

Pitfall 3: Clinician Resistance

The problem: You deploy an AI tool that’s technically sound and shows ROI in pilots. But clinicians don’t use it. They find workarounds. It sits idle.

How to avoid it:

• Involve clinicians early. Don’t build in isolation and then try to convince them to use it. Co-design with clinicians from day one.
• Redesign workflows around the AI tool, not the other way around. If the AI saves time, eliminate the saved work from the clinician’s day. Don’t just add the tool on top of existing work.
• Be transparent about limitations. If the AI is 90% accurate, say so. If it’s designed to assist, not replace, say so.
• Provide training and support. Clinicians need hands-on training, not just documentation.
• Listen to feedback and iterate. If clinicians say the tool is slowing them down, believe them and fix it.
• Celebrate wins. Share stories of clinicians who’ve benefited from the tool. Build momentum.

Pitfall 4: Regulatory Surprises

The problem: You deploy an AI system for months. Then a regulator asks questions: Is this a medical device? Where’s your validation study? Why aren’t you monitoring model performance? You’re unprepared.

How to avoid it:

• Understand regulatory requirements upfront. If your AI system diagnoses or treats disease, it’s a medical device. Know the FDA pathway.
• Build compliance into your architecture from day one. Don’t treat it as an afterthought.
• Document everything: how the model was built, what data was used, how it was validated, how it performs in production. You’ll need this for regulators.
• Establish governance and oversight. Have a process for reviewing and approving AI systems. Document the process.
• Monitor model performance continuously. If accuracy drops, have a plan to address it.
• PADISO’s security audit services include regulatory readiness assessment and help health systems prepare for SOC 2, ISO 27001, and clinical audit requirements.

Pitfall 5: ROI Illusions

The problem: You deploy an AI tool that saves clinicians time. You calculate ROI based on that time savings. But the saved time doesn’t translate to cost reduction or revenue increase. The tool looks good on paper but doesn’t move the needle on your bottom line.

How to avoid it:

• Define ROI upfront. What’s the financial impact of the problem you’re solving? Be specific.
• For time savings, calculate the actual cost impact. If an AI tool saves a radiologist 1 hour per day, what’s the value? Is it equivalent to hiring one fewer radiologist? Or does the radiologist just see more patients? Be clear.
• Measure end-to-end impact. An AI tool might save time, but if it increases error rate or reduces patient satisfaction, the net ROI might be negative.
• Track costs rigorously: vendor fees, infrastructure, integration work, training, support. Don’t underestimate.
• Compare to alternatives. Could you achieve the same outcome with process improvement or hiring? Is AI the best use of capital?

---

Next Steps: Building Your Operating Model

If you’re a health system leader thinking about AI strategy, here’s how to get started:

Month 1: Assess Your Current State

• Inventory your current AI initiatives. Which are working? Which are stalled? What’s the total spend?
• Audit your data infrastructure. Where is your data? Is it accessible for AI? What’s the quality?
• Assess your AI capability. Do you have data engineers, ML engineers, clinical informaticists? What gaps exist?
• Understand your regulatory posture. Which of your AI systems are medical devices? Are you audit-ready?

PADISO’s AI Quickstart Audit is a fixed-fee, 2-week diagnostic that tells you exactly where you are, what to ship first, what to retire, and what 90 days could unlock. It’s designed for health systems and other regulated industries.

Month 2–3: Define Your Strategy

• Establish an AI governance committee. Who should be involved? When will you meet?
• Define your AI strategy: which use cases will you prioritise? Why? What’s the expected ROI?
• Assess build vs. buy for your top 3–5 use cases. Which should you build? Which should you buy?
• Identify your top vendors. Run an evaluation process. Understand their clinical evidence, regulatory status, and integration requirements.
• Plan your data infrastructure investment. What’s the timeline? What’s the cost?

Month 4–6: Build Foundations

• Hire or bring in fractional leadership. You need a Chief Data Officer, VP of Engineering, or equivalent to guide strategy and execution.
• PADISO’s fractional CTO services provide exactly this kind of technical leadership for health systems.
• Start building your data infrastructure. Choose your cloud data warehouse. Begin ETL development.
• Establish governance processes. Define how you’ll review and approve new AI initiatives.
• Launch your first 1–2 strategic pilots with proper governance and change management.

Month 6–12: Execute and Learn

• Run your pilots. Measure outcomes rigorously. Iterate based on feedback.
• Build integration infrastructure. Don’t integrate vendor systems directly to your EHR; build an abstraction layer.
• Invest in clinician training and change management. This is as important as the technology.
• Monitor and optimise. Track data quality, model performance, clinician adoption.
• Plan scaling. If pilots succeed, what’s the rollout plan?

Year 2+: Scale and Optimise

• Scale successful pilots. Roll out in phases. Monitor closely.
• Expand your AI team. Hire or contract for capability gaps.
• Optimise vendor relationships. Consolidate overlapping tools. Negotiate better terms.
• Establish continuous improvement. Use feedback to iterate on tools and workflows.
• Plan the next phase. What’s your vision for AI in healthcare in 3–5 years? What capabilities do you need to build?

Key Takeaway

Building a healthcare AI operating model is a multi-year journey. It’s not about deploying the latest AI tool. It’s about building the governance, infrastructure, and capability to deploy AI safely, effectively, and at scale.

The organisations that get this right will have a significant competitive advantage. They’ll ship faster, spend less, retain clinician trust, and pass audits without panic. They’ll be the leaders in their markets.

Start today. Assess where you are. Define your strategy. Build your foundations. Execute disciplined pilots. Scale thoughtfully. You’ll get there.

If you need help, PADISO’s team of AI and platform specialists work with health systems, biotech companies, and other regulated organisations to build AI operating models that work. We provide fractional CTO leadership, platform engineering, custom AI development, and security audit readiness. Book a call to discuss your specific situation.

For health systems in Australia, PADISO’s Sydney-based team has deep experience with Australian regulatory requirements and can guide you through SOC 2 and ISO 27001 compliance as you scale AI. We work with health systems, private equity portfolio companies, and venture-backed startups in healthcare and adjacent industries.

---

Conclusion

Healthcare AI in 2026 is no longer a question of whether to adopt it. It’s a question of how to do it responsibly, sustainably, and at scale. The organisations that build a deliberate AI operating model—with clear governance, strong data foundations, vendor discipline, and clinician engagement—will lead their markets.

The time to build your operating model is now. Not after you’ve run 10 failed pilots. Not after you’ve accumulated technical debt and vendor lock-in. Now.

Start with assessment. Move to strategy. Build foundations. Execute pilots. Scale thoughtfully. You’ll build a healthcare AI operating model that works.

Research from peer-reviewed sources emphasises that successful healthcare AI deployment requires governance, clinical validation, and ongoing performance monitoring. Industry analyses confirm that health systems investing in AI infrastructure and governance are seeing measurable ROI and competitive advantage.

The healthcare AI leaders of 2026 are building their operating models today. Will you be one of them?